NIHR Archives - Page 2 of 3 -

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a

Virtual trials and the next generation of pharma clinical research

https://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Coordinating and delivering research in the pandemic: The UK approach

louise.bellamy@pharmaphorum.com clinical research, clinical trial regulation, clinical trials, coronavirus, COVID-19, NIHR, trial recruitment 0 Comment

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical

Coordinating and delivering research in the pandemic: The UK approach

https://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/

Patients/ Views & Analysis/ Views and analysis

2020 in review: COVID-19 and patient centric clinical trials

Amanda Barrell 2020 review, ABPI, clinical trials, COVID-19, NIHR, patient centricity, remote monitoring, vaccines 0 Comment

The trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp

2020 in review: COVID-19 and patient centric clinical trials

https://pharmaphorum.com/views-analysis-patients/2020-in-review-covid-19-and-patient-centric-clinical-trials/

Patients/ Views & Analysis/ Views and analysis

Does a lack of diversity in clinical trials reflect a lack of diversity among researchers?

Amanda Barrell diversity, inclusion, NIHR 0 Comment

Embedding diversity into clinical research does not start and end at trial recruitment – the community needs processes

Does a lack of diversity in clinical trials reflect a lack of diversity among researchers?

https://pharmaphorum.com/views-analysis-patients/does-a-lack-of-diversity-in-clinical-trials-reflect-a-lack-of-diversity-among-researchers/

R&D/ Views & Analysis/ Views and analysis

An introduction to the new NIHR National Patient Recruitment Centres

Richard Staines clinical trials, NIHR, NIHR National Patient Recruitment Centres, patient recruitment, research, UK, webinar 0 Comment

A new network of patient recruitment centres is set to shape the future of commercial clinical trials in

An introduction to the new NIHR National Patient Recruitment Centres

https://pharmaphorum.com/r-d/views-analysis-r-d/an-introduction-to-the-new-nihr-national-patient-recruitment-centres/

Patients/ Views & Analysis/ Views and analysis

Inclusive research and tackling health inequalities

Amanda Barrell COVID-19, ethnic diversity, health inequality, NHS, NIHR, patients, research 0 Comment

Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline

Inclusive research and tackling health inequalities

https://pharmaphorum.com/views-analysis-patients/inclusive-research-and-tackling-health-inequalities/

(781)NIHR-2nd-Webinar-Image-16x9-Text-v3

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Increasing patient engagement with UK clinical trials

louise.bellamy@pharmaphorum.com clinical trials, compliance, NHS, NIHR, patient engagement, Regulatory affairs, regulatory frameworks 0 Comment

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so

Increasing patient engagement with UK clinical trials

https://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/

Debates & Insights/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Introducing the new NIHR National Patient Recruitment Centres

louise.bellamy@pharmaphorum.com access to clinical trials, clinical trials, NHS, NIHR, virtual trials 0 Comment

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical

Introducing the new NIHR National Patient Recruitment Centres

https://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/

News/ News/ R&D

Government needs strategy to kick-start R&D after COVID, says pharma body

Richard Staines ABPI, coronavirus, COVID-19, NIHR 0 Comment

The UK has been leading research into the COVID-19 outbreak, according to the country’s pharma trade body, but

Government needs strategy to kick-start R&D after COVID, says pharma body

https://pharmaphorum.com/news/uk-pharma-calls-for-non-covid-research-to-restart/

Trending

NIHR

Login